These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8152580)

  • 1. [Kinetics of breast neoplasms].
    Surbone A; Norton L
    Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
    Frei E; Richardson P; Avigan D; Bunnell C; Wheeler C; Elias A
    Bone Marrow Transplant; 1999 Nov; 24(9):939-45. PubMed ID: 10556951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gompertzian model of human breast cancer growth.
    Norton L
    Cancer Res; 1988 Dec; 48(24 Pt 1):7067-71. PubMed ID: 3191483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling multi-drug chemotherapy: tailoring treatment to individuals.
    Gardner SN
    J Theor Biol; 2002 Jan; 214(2):181-207. PubMed ID: 11812172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stochastic numerical model of breast cancer growth that simulates clinical data.
    Speer JF; Petrosky VE; Retsky MW; Wardwell RH
    Cancer Res; 1984 Sep; 44(9):4124-30. PubMed ID: 6744323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy for breast cancer.
    Hennessy BT; Pusztai L
    Minerva Ginecol; 2005 Jun; 57(3):305-26. PubMed ID: 16166938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing drug resistance. The somatic mutation model and gestational trophoblastic neoplasia.
    Dembo AJ
    J Reprod Med; 1987 Sep; 32(9):669-74. PubMed ID: 2822921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality approach for high-risk breast cancer. The Milan Cancer Institute experience.
    Bonadonna G; Valagussa P
    Surg Oncol Clin N Am; 1995 Oct; 4(4):701-14. PubMed ID: 8535906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869.
    Kute TE; Quadri Y; Muss H; Zbieranski N; Cirrincione C; Berry DA; Barcos M; Thor AP; Liu E; Koerner F
    Cytometry; 1995 Dec; 22(4):297-306. PubMed ID: 8749780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer: A medical emergency.
    Harless W; Qiu Y
    Med Hypotheses; 2006; 67(5):1054-9. PubMed ID: 16824693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.